Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.
about
Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplexMouse models to study dengue virus immunology and pathogenesisRational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaquesTwo Complex, Adenovirus-Based Vaccines That Together Induce Immune Responses to All Four Dengue Virus SerotypesAn adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypesVaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1Transcriptional Activation of Interferon-Stimulated Genes but Not of Cytokine Genes after Primary Infection of Rhesus Macaques with Dengue Virus Type 1Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteersA Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue VirusIRES-dependent replication of Venezuelan equine encephalitis virus makes it highly attenuated and incapable of replicating in mosquito cellsConstruction and Characterization of a Single-Cycle Chimeric Flavivirus Vaccine Candidate That Protects Mice against Lethal Challenge with Dengue Virus Type 2Structural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine DevelopmentNatural Strain Variation and Antibody Neutralization of Dengue Serotype 3 VirusesThe complexity of antibody-dependent enhancement of dengue virus infectionA non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 miceA genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent miceScreening for immune response against Dengue virus in Vietnamese non-human primates: implications for vaccine developersIssues related to recent dengue vaccine development.The 5' and 3' Untranslated Regions of the Flaviviral Genome.A single dose of the DENV-1 candidate vaccine rDEN1Δ30 is strongly immunogenic and induces resistance to a second dose in a randomized trial.Report of an NIAID workshop on dengue animal models.Dengue vaccines: state of the art.Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization.Utility, limitations, and future of non-human primates for dengue research and vaccine developmentVirus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccineEfficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaquesAn adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaques.Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms.Distinct Humoral and Cellular Immunity Induced by Alternating Prime-boost Vaccination Using Plasmid DNA and Live Viral Vector Vaccines Expressing the E Protein of Dengue Virus Type 2Models of dengue virus infection.Targeted mutagenesis as a rational approach to dengue virus vaccine development.An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection.Potential of ancestral sylvatic dengue-2 viruses to re-emerge.Dengue viruses cluster antigenically but not as discrete serotypesDengue Vaccine: The Current StatusMacaque models of human infectious disease.Evaluation of protective efficacy using a nonstructural protein NS1 in DNA vaccine-loaded microspheres against dengue 2 virus.Mouse models of dengue virus infection and disease.Recombinant vesicular stomatitis virus-based dengue-2 vaccine candidate induces humoral response and protects mice against lethal infection.
P2860
Q24737461-4AE8D5D3-336F-438D-8BD9-A334C96E6F7DQ27010151-3665D4D7-7324-4B80-B425-FED7AF15485FQ27334248-973104CD-FE87-4ECB-93B2-FB9CA9114436Q27478075-6CFF29DB-34AA-4E2C-AF22-1F7212094DB7Q27478104-6DE98122-0A67-4EB1-AA5E-D5436337FB99Q27478162-6F2A6852-A530-4C99-AA02-45152C857A8EQ27480996-E2D6EA7D-E54E-4F93-A471-AC03701D4050Q27485404-960E839A-35B7-4A62-ADF5-0143FB6743C6Q27485433-2D27DE54-5A6D-4C3D-93F4-56CFE193C717Q27486406-CCF4AA3B-A00F-4013-BCE7-DD2D2F0C96C3Q27486518-9CF3F73C-DFF5-4E2E-ABC5-323E232706BBQ27487946-DDDF7F7E-F914-437F-8AE9-687F1B5A10B9Q27488364-01600C13-20C7-4FFD-9FEE-3879586098FEQ27491299-953DEB95-96C1-4AEF-B9A6-0932A2F0F3E3Q28250383-C3E60F86-3AD9-453A-92CE-462A1238883AQ28473775-225D3446-8015-4099-971B-FA0CE98B8DABQ28483765-FCDB0FBC-DB07-40D0-91A1-4376E51CAE6AQ29365117-3AE15F5B-291E-46B1-B209-712CF542F1F2Q30395396-0487FC7B-D933-405D-9C1A-DBAB17148B42Q32183359-A516C75C-C213-451E-A15A-7243C0182A83Q33988937-B07BB6DF-4710-4E18-B0FC-A3EB1A9EAF3DQ34058747-C6EA7C52-D221-42FA-B1F1-C761D73B6C69Q34109652-851F31FB-B7BB-4C29-8DAD-B1543ADD2A5CQ34184711-6120D0A3-AB75-4AF8-985F-95D9F31C18A4Q34238916-598703FC-D6B4-4D38-A0A2-E4655808DD53Q34262245-47960A1E-A41A-41E2-B68C-D195FE69F662Q35031833-129C84D7-1F05-4940-AC06-73E85CB9478AQ35272502-2420E2A5-4C7E-4BD8-AE76-EF1DDE769690Q35531167-A2F93038-EAD2-48AF-A832-CA81CB71E83EQ35624552-586007FB-21F9-435D-B8A7-6E9CAAC34FF7Q35942502-876D3B25-6C64-4DF5-8147-E4EA660B6894Q36118259-25A55631-70CD-486B-A8AD-54E01210A7FCQ36667964-91C8CEB3-C3F4-45FC-970B-9EC05E57D877Q36718596-5454AB25-14F5-4788-860A-A456C6B8E72DQ36926525-5C1595F2-F83A-4134-BED8-7A69FF6EFA8FQ37039194-C4D95BF5-1FC0-48F6-9BEB-E76B2C1700D7Q37103536-C293B9B9-A881-4DAA-AB03-0FEF003F39F0Q37120632-07BCFECB-2237-4650-ADE6-B167B92C5411Q37213365-E125ACBF-7904-443F-BC7E-9368FB12F654Q37265013-44EA1B91-AC56-4518-9ACC-A21BA1C3D35F
P2860
Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Recombinant, Live-Attenuated T ...... ur Serotypes in Rhesus Monkeys
@nl
Recombinant, live-attenuated t ...... r serotypes in rhesus monkeys.
@ast
Recombinant, live-attenuated t ...... r serotypes in rhesus monkeys.
@en
type
label
Recombinant, Live-Attenuated T ...... ur Serotypes in Rhesus Monkeys
@nl
Recombinant, live-attenuated t ...... r serotypes in rhesus monkeys.
@ast
Recombinant, live-attenuated t ...... r serotypes in rhesus monkeys.
@en
prefLabel
Recombinant, Live-Attenuated T ...... ur Serotypes in Rhesus Monkeys
@nl
Recombinant, live-attenuated t ...... r serotypes in rhesus monkeys.
@ast
Recombinant, live-attenuated t ...... r serotypes in rhesus monkeys.
@en
P2093
P2860
P921
P1433
P1476
Recombinant, live-attenuated t ...... r serotypes in rhesus monkeys.
@en
P2093
Brian R Murphy
Jennifer M Matro
Joseph E Blaney
P2860
P304
P356
10.1128/JVI.79.9.5516-5528.2005
P5008
P577
2005-05-01T00:00:00Z